Yufeng Cheng

No ORCID on file · 3 papers in corpus
lab-animal 2026
Dual-Targeted Nanotherapy Restores Redox Homeostasis and Suppresses Uterine Hypercontractility for Effective Preterm Birth Intervention
Advanced healthcare materials ·doi:10.1002/adhm.71198

Preterm birth (PTB), defined as delivery between 28 and 37 weeks of gestation, is a leading cause of global neonatal mortality. Its pathogenesis is primarily driven by oxidative stress and inflammation, synergistically inducing calcium ion …

other 2026
Multi-omics Mendelian randomization integrating metabolism, microbiome and immunity supports a putative gut-immune-pelvic pathway in deep infiltrating endometriosis
Frontiers in endocrinology ·doi:10.3389/fendo.2026.1827134

BACKGROUND: Deep infiltrating endometriosis (DIE) is a highly fibrotic and deeply invasive subtype of endometriosis that causes severe pelvic pain, infertility and marked impairment of quality of life. Metabolic, microbial and immune distur…

observational 2023
The use of IVF/ICSI and risk of postpartum hemorrhage: A retrospective cohort study of 153,765 women in China
Frontiers in public health ·doi:10.3389/fpubh.2023.1016457

OBJECTIVE: Postpartum hemorrhage (PPH) is the leading cause of maternal morbidity and mortality. Identifying women who are at high risk of PPH is crucial for implementing early preventive and interventive strategies. This study aimed to exa…